AIM ImmunoTech Inc. (AIM) Business Metric Overview - Stocknear

AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Sep 05, 2025, 3:59 PM
2.54
1.20%
After-hours: Sep 05, 2025, 07:34 PM EDT

AIM ImmunoTech Revenue Breakdown

Period Ending Dec 31, 2022 Jun 30, 2022
Clinical Treatment Programs - US Revenue 111K 30K
Clinical Treatment Programs - US Revenue Growth +270.00% n/a

Revenue by Geography

Period Ending Jun 30, 2021
United States Revenue 23K
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 1.49M 2.54M 4.29M 3.08M 2.59M 3.76M 10.8M 5.44M 2.55M 2.29M 3.5M 5.17M 2.18M 2.07M 2.62M 1.8M 2.15M 2.11M 2.58M 2.08M 1.72M 2.27M 1.48M 1.85M 1.94M 1.77M 1.63M 1.27M 1.73M 1.56M 1.73M 1.56M 1.62M 1.66M 1.96M 1.63M 1.64M 2.45M 1.55M 1.69M 2M 1.91M
Selling, General, and Administrative Revenue Growth -41.57% -40.63% +39.23% +18.83% -31.04% -65.21% +98.55% +113.29% +11.26% -34.61% -32.21% +137.05% +5.26% -20.83% +45.47% -16.13% +1.56% -18.27% +23.93% +21.43% -24.29% +52.83% -19.61% -4.94% +9.90% +8.27% +28.20% -26.54% +10.88% -9.81% +11.38% -3.89% -2.70% -15.10% +19.95% -0.31% -33.05% +58.24% -8.19% -15.83% +4.65% n/a
Research and Development Revenue 1.17M 1.08M 1.66M 1.44M 1.15M 1.95M 3.19M 2.73M 2.95M 2.05M 2.11M 1.37M 2.48M 1.04M 2.92M 2.01M 1.32M 1.42M 2.27M 1.1M 1.46M 898K 1.44M 1.19M 1.1M 928K 987K 1.59M 1.34M 855K 814K 787K 1.11M 1.39M 1.86M 1.34M 900K 1M 957K 1.97M 2.44M 2.67M
Research and Development Revenue Growth +8.70% -35.10% +15.80% +25.50% -41.31% -38.76% +16.53% -7.42% +43.91% -2.61% +53.57% -44.57% +138.90% -64.56% +45.71% +52.32% -7.51% -37.41% +106.44% -24.68% +62.92% -37.51% +20.76% +8.58% +18.10% -5.98% -38.12% +18.94% +56.84% +5.04% +3.43% -28.84% -20.49% -25.34% +38.82% +49.11% -10.18% +4.70% -51.37% -19.31% -8.79% n/a